104 related articles for article (PubMed ID: 10240436)
1. Do-it-yourself doctoring.
Grossmann J
Fam Health; 1979 Feb; 11(2):20-4. PubMed ID: 10240436
[No Abstract] [Full Text] [Related]
2. Automated ambulatory blood pressure devices and self-measured blood pressure monitoring devices: their role in the diagnosis and management of hypertension. American College of Physicians.
Ann Intern Med; 1993 Jun; 118(11):889-92. PubMed ID: 8480963
[No Abstract] [Full Text] [Related]
3. Dietary supplements--regulatory issues and implications for public health.
Denham BE
JAMA; 2011 Jul; 306(4):428-9. PubMed ID: 21730229
[No Abstract] [Full Text] [Related]
4. The Dietary Supplement Health and Education Act.
Young AL; Bass IS
Food Drug Law J; 1995; 50(2):285-92. PubMed ID: 10342995
[No Abstract] [Full Text] [Related]
5. The impact of FDA reform.
Trunzo J
Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
[TBL] [Abstract][Full Text] [Related]
6. Dietary supplements: background for dialogue between the industry and the medical profession.
Friede AI
Food Drug Law J; 1998; 53(3):413-20. PubMed ID: 10346719
[No Abstract] [Full Text] [Related]
7. Industry effects of medical device regulation: the case of diagnostic imaging equipment.
McKay NL
J Policy Anal Manage; 1986; 6(1):35-44. PubMed ID: 10279385
[TBL] [Abstract][Full Text] [Related]
8. Enforcement policy: recalls (including product corrections)--guidelines on policy, procedures, and industry responsibilities.
Fed Regist; 1978 Jun; 43(117):26201-21. PubMed ID: 10316619
[No Abstract] [Full Text] [Related]
9. FDA's regulation of prescription drug labeling: a role for implied preemption.
Kendrick LC
Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
[No Abstract] [Full Text] [Related]
10. Ambiguities of the Dietary Supplement Health and Education Act of 1994.
Pinco RG; Rubin PD
Food Drug Law J; 1996; 51(3):383-405. PubMed ID: 11797716
[No Abstract] [Full Text] [Related]
11. The end of paternalism: a new approach to food labeling.
Steinborn SB; Todd KA
Food Drug Law J; 1999; 54(3):401-22. PubMed ID: 11797706
[No Abstract] [Full Text] [Related]
12. F.D.A. regulation of medical devices: the Federal Register tells the tale.
Dobelle WH
Man Med; 1978; 3(3):221-8. PubMed ID: 10316739
[No Abstract] [Full Text] [Related]
13. RU 486 and the politics of drug regulation in the United States and France.
Kramnick RK
Cornell Int Law J; 1992; 25():667-718. PubMed ID: 11656340
[No Abstract] [Full Text] [Related]
14. Ethical and economic questions in the reuse of single use devices.
Willingmyre GT
Healthspan; 1985 Jul; 2(7):3-6. PubMed ID: 10272747
[No Abstract] [Full Text] [Related]
15. "It's time to make a good agency better": the Food and Drug Administration Modernization Act of 1997 and the First Amendment.
Murphy AM
Food Drug Law J; 1998; 53(4):603-25. PubMed ID: 10557579
[No Abstract] [Full Text] [Related]
16. Off-label promotion: is FDA's final guidance on industry-supported scientific and educational programs enforceable?
Bass IS; Kalb PE; Berenson BA
Food Drug Law J; 1998; 53(2):193-212. PubMed ID: 10346681
[No Abstract] [Full Text] [Related]
17. A survey of developments in food and drug law from July 1998 to November 1999.
Littlefield N; Hada NR
Food Drug Law J; 2000; 55(1):35-56. PubMed ID: 12296348
[No Abstract] [Full Text] [Related]
18. Commentary: can we talk? About Food and Drug Regulation and the First Amendment.
Cohen MN
Food Drug Law J; 2003; 58(4):741-56. PubMed ID: 15027458
[No Abstract] [Full Text] [Related]
19. The public health responsibilities of physicians.
Goddard JL
J Am Osteopath Assoc; 1969 Aug; 68(12):240-3. PubMed ID: 5195924
[No Abstract] [Full Text] [Related]
20. Education or promotion?: Industry-sponsored continuing medical education (CME) as a center for the core/commercial speech debate.
Chen P;
Food Drug Law J; 2003; 58(3):473-509. PubMed ID: 14626981
[No Abstract] [Full Text] [Related]
[Next] [New Search]
